Exelixis (EXEL) Share-based Compensation Growth (1y) (2011 - 2026)
Exelixis (EXEL) Share-based Compensation Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 118.32% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -40.86% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 0.18% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 5,886.05% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Exelixis | 14.38 Bn | 13.60 Bn | 590.86 Mn | 52.03% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 52.03% |
| Jan 2, 2026 | 138.52% |
| Oct 3, 2025 | -34.95% |
| Jul 4, 2025 | 4,282.35% |
| Apr 4, 2025 | 17.80% |
| Jan 3, 2025 | -701.12% |
| Sep 27, 2024 | 397.03% |
| Jun 28, 2024 | -91.83% |
| Mar 29, 2024 | 647.48% |
| Dec 29, 2023 | -107.12% |
| Sep 29, 2023 | 93.87% |
| Jun 30, 2023 | 228.30% |
| Mar 31, 2023 | -87.06% |
| Dec 30, 2022 | 167.38% |
| Jul 1, 2022 | -1,468.43% |
| Apr 1, 2022 | 263.15% |
| Dec 31, 2021 | 5,180.09% |
| Apr 2, 2021 | -61.09% |
| Apr 3, 2020 | 11.60% |
| Sep 27, 2019 | -96.31% |